Viewing Study NCT01449357


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2025-12-25 @ 4:12 PM
Study NCT ID: NCT01449357
Status: WITHDRAWN
Last Update Posted: 2011-10-10
First Post: 2011-09-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors
Sponsor: Genmab
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module